Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.4396
Delayed Data
As of May 27
 -0.0127 / -2.81%
Today’s Change
0.39
Today|||52-Week Range
6.49
-85.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues47.0M48.6M46.4M32.5M
 
 
 
 
 
Cost of Goods Sold13.8M12.0M14.5M11.2M
 
 
 
 
 
Depreciation And Amortization22.3M25.7M28.2M23.7M
 
 
 
 
 
 
Operating ExpensesGross Income10.9M10.8M3.7M-2.4M
 
 
 
 
 
General Expenses23.2M30.4M26.7M26.9M
 
 
 
 
 
Research And Development1.5M3.2M2.6M928.0K
 
 
 
 
 
Total Operating Expenses59.3M68.2M69.4M61.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-19.6M-23.1M-29.3M
 
 
 
 
 
Extraordinary Credit8.7M14.1M141.0K12.3M
 
 
 
 
 
Extraordinary Charge-22.5M-1.3M-27.8M--
 
 
 
 
Interest Expense On Debt9.9M9.7M9.3M9.0M
 
 
 
 
 
Other Expenses0.000.00-582.0K138.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.8M-16.4M-60.8M-25.9M
 
 
 
 
 
Income Taxes-3.6M-5.6M-20.9M-35.0K
 
 
 
 
 
Net Income-32.2M-10.7M-81.7M-25.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.4M61.0M61.1M61.1M
 
 
 
 
 
Shares To Calculate EPS Diluted52.4M61.0M61.1M61.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$0.18-$1.34-$0.42
 
 
 
 
 
EPS Diluted-$0.62-$0.18-$1.34-$0.42